Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance.


Journal

Molecular cancer
ISSN: 1476-4598
Titre abrégé: Mol Cancer
Pays: England
ID NLM: 101147698

Informations de publication

Date de publication:
12 03 2020
Historique:
received: 15 12 2019
accepted: 02 03 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 3 2 2021
Statut: epublish

Résumé

Early-stage detection of leukemia is a critical determinant for successful treatment of the disease and can increase the survival rate of leukemia patients. The factors limiting the current screening approaches to leukemia include low sensitivity and specificity, high costs, and a low participation rate. An approach based on novel and innovative biomarkers with high accuracy from peripheral blood offers a comfortable and appealing alternative to patients, potentially leading to a higher participation rate.Recently, non-coding RNAs due to their involvement in vital oncogenic processes such as differentiation, proliferation, migration, angiogenesis and apoptosis have attracted much attention as potential diagnostic and prognostic biomarkers in leukemia. Emerging lines of evidence have shown that the mutational spectrum and dysregulated expression of non-coding RNA genes are closely associated with the development and progression of various cancers, including leukemia. In this review, we highlight the expression and functional roles of different types of non-coding RNAs in leukemia and discuss their potential clinical applications as diagnostic or prognostic biomarkers and therapeutic targets.

Identifiants

pubmed: 32164715
doi: 10.1186/s12943-020-01175-9
pii: 10.1186/s12943-020-01175-9
pmc: PMC7069174
doi:

Substances chimiques

Biomarkers, Tumor 0
RNA, Long Noncoding 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

57

Commentaires et corrections

Type : ErratumIn

Références

Cancer Discov. 2011 Oct;1(5):391-407
pubmed: 22096659
Leukemia. 2017 Nov;31(11):2315-2325
pubmed: 28216661
Int J Hematol. 2015 Sep;102(3):296-303
pubmed: 26134365
J Cell Biochem. 2013 Oct;114(10):2375-83
pubmed: 23649634
Int J Mol Sci. 2016 Dec 10;17(12):
pubmed: 27973410
Cancer Lett. 2018 Sep 1;431:11-21
pubmed: 29800684
Elife. 2014 Apr 29;3:e01776
pubmed: 24843008
J Cancer Res Clin Oncol. 2016 Jan;142(1):77-87
pubmed: 26113450
Oncol Lett. 2016 Nov;12(5):3531-3536
pubmed: 27900032
Onco Targets Ther. 2017 Apr 07;10:2045-2056
pubmed: 28435295
Cell Tissue Res. 2015 Jan;359(1):225-54
pubmed: 25416506
Leukemia. 2020 May;34(5):1253-1265
pubmed: 31768018
Gene. 2017 Aug 30;626:106-118
pubmed: 28512058
Brief Funct Genomics. 2016 May;15(3):239-48
pubmed: 26647283
Oncol Res. 2019 Feb 14;:
pubmed: 30764894
Blood. 2011 Jan 13;117(2):563-74
pubmed: 20940416
Biomed Rep. 2019 Feb;0(0):1-5
pubmed: 30842885
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7364-7370
pubmed: 30468482
Br J Haematol. 2013 Oct;163(1):93-103
pubmed: 23888996
Nat Rev Mol Cell Biol. 2016 Apr;17(4):205-11
pubmed: 26908011
Science. 2017 Sep 22;357(6357):
pubmed: 28798046
Cancer Gene Ther. 2015 Dec;22(12):573-80
pubmed: 26494558
Cancer Med. 2014 Aug;3(4):878-88
pubmed: 24902858
RNA. 2015 Feb;21(2):172-9
pubmed: 25449546
Cancers (Basel). 2019 Oct 10;11(10):
pubmed: 31658667
Acta Biochim Biophys Sin (Shanghai). 2009 Aug;41(8):699-708
pubmed: 19657571
Oncol Rep. 2018 Sep;40(3):1601-1613
pubmed: 29956795
Hum Mol Genet. 2015 Nov 1;24(21):6240-53
pubmed: 26307088
Gene. 2019 Apr 15;692:35-43
pubmed: 30639603
DNA Cell Biol. 1998 Jun;17(6):519-27
pubmed: 9655245
Nat Commun. 2017 Aug 9;8(1):218
pubmed: 28794406
Biomed Pharmacother. 2016 Feb;77:65-71
pubmed: 26796267
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
Int J Oncol. 2014 Jul;45(1):383-92
pubmed: 24756163
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):763-770
pubmed: 29461608
N Engl J Med. 2009 Sep 24;361(13):1235-48
pubmed: 19776405
Cancers (Basel). 2015 Apr 09;7(2):598-616
pubmed: 25860815
Nucleic Acids Res. 2014 Sep;42(15):9588-601
pubmed: 25092925
PLoS Genet. 2013 Apr;9(4):e1003373
pubmed: 23593011
Cell Cycle. 2010 Mar 15;9(6):1037-42
pubmed: 20237425
Curr Biol. 2002 Apr 30;12(9):735-9
pubmed: 12007417
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Blood. 2010 May 27;115(21):4191-7
pubmed: 20089965
Cell. 2014 Sep 25;159(1):13-14
pubmed: 25259915
J Hematol Oncol. 2016 May 04;9(1):44
pubmed: 27146823
Int J Cancer. 2017 Feb 1;140(3):653-661
pubmed: 27770540
RNA Biol. 2014;11(6):777-87
pubmed: 24824789
Arch Pharm Res. 2014 Jan;37(1):4-15
pubmed: 24272889
Nat Neurosci. 2015 Apr;18(4):603-610
pubmed: 25714049
Hematology. 2017 May;22(4):208-216
pubmed: 27875938
RNA. 2015 Dec;21(12):2007-22
pubmed: 26574518
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D109-11
pubmed: 14681370
Med Sci Monit. 2017 Oct 01;23:4705-4714
pubmed: 28965123
Trends Genet. 2009 Mar;25(3):120-8
pubmed: 19171405
Nat Commun. 2015 Mar 27;6:6520
pubmed: 25813522
Cell Physiol Biochem. 2018;47(5):1998-2007
pubmed: 29969755
Cancer Biomark. 2018;22(4):799-805
pubmed: 29945348
J Cell Biochem. 2018 Jul;119(7):6024-6032
pubmed: 29630744
PLoS One. 2013 Apr 16;8(4):e61858
pubmed: 23613955
Leukemia. 2010 Jan;24(1):89-96
pubmed: 19890372
Blood. 2009 Mar 12;113(11):2526-34
pubmed: 19144990
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11511-6
pubmed: 23798388
Diagn Pathol. 2014 Mar 29;9:76
pubmed: 24678958
J Hematol Oncol. 2019 May 24;12(1):51
pubmed: 31126316
Blood. 2010 Jan 21;115(3):453-74
pubmed: 19880497
Ann Hematol. 2018 Aug;97(8):1375-1389
pubmed: 29654398
J Anim Sci Technol. 2018 Oct 25;60:25
pubmed: 30386629
Expert Opin Pharmacother. 2012 Jul;13(10):1495-505
pubmed: 22663160
Nature. 2005 Dec 1;438(7068):685-9
pubmed: 16258535
Cancer Lett. 2015 Jan 28;356(2 Pt B):597-605
pubmed: 25305453
J Cell Biochem. 2020 Feb;121(2):1023-1031
pubmed: 31452272
Aging (Albany NY). 2019 Jun 1;11(11):3561-3573
pubmed: 31152142
Leuk Lymphoma. 2014 Jun;55(6):1373-82
pubmed: 23906015
Leuk Res. 2012 Mar;36(3):293-8
pubmed: 22099053
Oncotarget. 2015 Jul 30;6(21):18534-44
pubmed: 26053097
FEBS Lett. 2014 May 2;588(9):1780-6
pubmed: 24685695
Best Pract Res Clin Haematol. 2009 Dec;22(4):529-36
pubmed: 19959104
Cell. 2016 Apr 7;165(2):289-302
pubmed: 27040497
PLoS Genet. 2013;9(9):e1003777
pubmed: 24039610
Nucleic Acids Res. 2002 Jan 1;30(1):38-41
pubmed: 11752248
Mol Cell. 2014 Aug 21;55(4):604-14
pubmed: 25087872
Nucleic Acids Res. 2016 Apr 7;44(6):2846-58
pubmed: 26861625
Biomed Res Int. 2015;2015:851841
pubmed: 25815339
Nat Genet. 2006 Jun;38 Suppl:S8-13
pubmed: 16736023
Ann Transl Med. 2015 Dec;3(21):332
pubmed: 26734642
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Future Oncol. 2019 Mar;15(7):763-776
pubmed: 30501399
Sci Rep. 2015 Sep 02;5:13749
pubmed: 26330272
Clin Chim Acta. 2014 Apr 20;431:255-9
pubmed: 24583225
J Cancer Res Clin Oncol. 2017 Jun;143(6):1005-1011
pubmed: 28286901
Cell Physiol Biochem. 2018;51(2):886-896
pubmed: 30466095
Oncotarget. 2019 Sep 03;10(51):5313-5331
pubmed: 31523391
Biomed Pharmacother. 2019 Apr;112:108720
pubmed: 30970520
PLoS One. 2012;7(4):e35501
pubmed: 22511990
Nucleic Acids Res. 2011 Sep 1;39(16):6908-18
pubmed: 21586588
World J Gastroenterol. 2007 Jan 28;13(4):497-502
pubmed: 17278213
Nucleic Acids Res. 2018 Sep 19;46(16):8168-8180
pubmed: 30124921
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
Cell. 2013 Feb 14;152(4):727-42
pubmed: 23415223
Blood. 2010 Mar 4;115(9):1768-78
pubmed: 20029046
Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8
pubmed: 17991681
EMBO J. 2013 Apr 3;32(7):923-5
pubmed: 23463100
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):1-8
pubmed: 30366670
Blood Cells Mol Dis. 2019 Mar;75:41-47
pubmed: 30612066
Nat Genet. 2013 Nov;45(11):1268-9
pubmed: 24165726
J Oncol. 2019 Jul 30;2019:7239206
pubmed: 31467542
Cell. 1993 Dec 3;75(5):855-62
pubmed: 8252622
Development. 2016 Jun 1;143(11):1838-47
pubmed: 27246710
Haematologica. 2011 May;96(5):703-11
pubmed: 21242186
Cell. 2015 Mar 12;160(6):1125-34
pubmed: 25768908
Mol Cancer. 2016 May 27;15(1):43
pubmed: 27233618
Biochem Biophys Res Commun. 2018 Sep 3;503(1):385-390
pubmed: 29902450
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9511-9520
pubmed: 31000603
Genome Biol. 2015 Mar 12;16:52
pubmed: 25887447
PLoS One. 2016 Jul 08;11(7):e0158347
pubmed: 27391479
Blood. 2008 May 15;111(10):5078-85
pubmed: 18337557
J Hematol Oncol. 2015 Nov 06;8:126
pubmed: 26545364
Oncogene. 1997 Nov 13;15(20):2463-73
pubmed: 9395242
Nat Rev Genet. 2014 Jun;15(6):423-37
pubmed: 24776770
Science. 2016 Apr 8;352(6282):227-31
pubmed: 26966191
Clin Epigenetics. 2019 Feb 11;11(1):25
pubmed: 30744689
Cancer Biomark. 2019;26(1):93-108
pubmed: 31356197
Front Biosci. 2008 Jan 01;13:2537-47
pubmed: 17981733
Science. 2014 Apr 18;344(6181):310-3
pubmed: 24744378
Leuk Res. 2013 Mar;37(3):349-56
pubmed: 23287430
Blood. 2016 Aug 18;128(7):e10-9
pubmed: 27381906
Nature. 2011 Apr 7;472(7341):120-4
pubmed: 21423168
Curr Opin Investig Drugs. 2006 Jun;7(6):560-4
pubmed: 16784027
Nucleic Acids Res. 2017 Feb 17;45(3):1091-1104
pubmed: 28180285
Blood. 2015 Sep 10;126(11):1314-23
pubmed: 26138686
J Cell Biochem. 2018 Jul;119(7):6296-6308
pubmed: 29663500
Oncol Lett. 2019 Sep;18(3):2203-2211
pubmed: 31452721
Nature. 2013 Feb 28;494(7438):497-501
pubmed: 23417068
Oncol Lett. 2019 Feb;17(2):2081-2090
pubmed: 30675275
Curr Opin Hematol. 2017 Jul;24(4):353-358
pubmed: 28441150
Oncotarget. 2017 Apr 18;8(16):25942-25954
pubmed: 28412730
Sci Rep. 2016 Jan 12;6:19204
pubmed: 26754824
Curr Pharm Biotechnol. 2014;15(5):492-502
pubmed: 24846063
Environ Toxicol Pharmacol. 2017 Oct;55:81-86
pubmed: 28841440
Leukemia. 2014 May;28(5):1022-32
pubmed: 24270738
Microrna. 2014;2(3):158-64
pubmed: 25069439
Cir Esp. 2014 Dec;92(10):654-8
pubmed: 25088411
Cell Death Dis. 2018 May 29;9(6):651
pubmed: 29844435
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
J Cell Biochem. 2018 May;119(5):3843-3852
pubmed: 29058777
Nature. 2014 Aug 7;512(7512):82-6
pubmed: 25043044
J Cell Biochem. 2019 Apr;120(4):6315-6321
pubmed: 30362157
PLoS One. 2015 Oct 20;10(10):e0141214
pubmed: 26485708
Biomol Ther (Seoul). 2017 Sep 1;25(5):490-496
pubmed: 28190319
Blood Cells Mol Dis. 2018 Nov;73:38-44
pubmed: 30224298
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Oncogene. 1998 Apr 9;16(14):1891-7
pubmed: 9583687
RNA. 2019 Dec;25(12):1765-1778
pubmed: 31519742
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5078-83
pubmed: 16549775
Mol Cell Biol. 2018 Sep 28;38(20):
pubmed: 30037980
Hematol Oncol. 2019 Oct;37(4):474-482
pubmed: 31325181
N Engl J Med. 2015 Sep 17;373(12):1136-52
pubmed: 26376137
Hepatology. 2017 Oct;66(4):1151-1164
pubmed: 28520103
Cancer Res. 2017 Aug 1;77(15):3965-3981
pubmed: 28701486
Cell. 2014 Jul 31;158(3):593-606
pubmed: 25083870
Gene. 2019 Jul 30;707:172-177
pubmed: 30943439
Int J Clin Exp Pathol. 2015 Nov 01;8(11):14658-66
pubmed: 26823789
Genome Biol. 2014 Jul 29;15(7):409
pubmed: 25070500
Am J Cancer Res. 2015 Jan 15;5(2):472-80
pubmed: 25973291
Am J Hematol. 2014 May;89(5):480-6
pubmed: 24415640
Mol Cancer. 2011 Sep 01;10:108
pubmed: 21880154
Clin Chim Acta. 2015 May 20;445:25-33
pubmed: 25773117
Biochem Biophys Res Commun. 2018 Oct 12;504(4):660-665
pubmed: 30205959
Oncotarget. 2017 Feb 7;8(6):10726-10740
pubmed: 27802187
Blood Cancer J. 2016 Oct 14;6(10):e483
pubmed: 27740630
Leukemia. 2015 Oct;29(10):2015-23
pubmed: 25971364
Nature. 2005 Jul 14;436(7048):214-20
pubmed: 15951802
Biomed Pharmacother. 2019 Jan;109:1793-1801
pubmed: 30551433
Mol Cancer. 2016 May 14;15(1):37
pubmed: 27179712
Nature. 2004 Sep 16;431(7006):350-5
pubmed: 15372042
Mol Med Rep. 2014 May;9(5):1909-16
pubmed: 24604579
Int J Mol Sci. 2017 Mar 09;18(3):
pubmed: 28282919
Leuk Lymphoma. 2009 Mar;50(3):502-5
pubmed: 19347735
Sci Rep. 2015 Aug 26;5:13445
pubmed: 26306906
Biochim Biophys Acta. 2016 Jan;1859(1):163-8
pubmed: 26171810
Int J Mol Sci. 2019 Feb 09;20(3):
pubmed: 30744139
Oncogene. 2015 Apr 2;34(14):1768-79
pubmed: 24837367
Leuk Res. 2013 Dec;37(12):1690-6
pubmed: 24199710
Haematologica. 2012 Apr;97(4):586-94
pubmed: 22102710
DNA Cell Biol. 2017 Jan;36(1):18-25
pubmed: 27854515
Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):47-55
pubmed: 24629639
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Leuk Lymphoma. 2017 Aug;58(8):1948-1957
pubmed: 27951730
Mol Cells. 2016 Apr 30;39(4):330-6
pubmed: 26923190
Exp Ther Med. 2018 Sep;16(3):1693-1700
pubmed: 30186389
Genome Res. 2003 Jul;13(7):1737-43
pubmed: 12840048
BMC Cancer. 2014 Sep 23;14:693
pubmed: 25245097
Arch Otolaryngol Head Neck Surg. 1989 Aug;115(8):964-9
pubmed: 2751856
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Ann Oncol. 2007 Jan;18 Suppl 1:i3-i8
pubmed: 17311819
Cell Metab. 2006 Feb;3(2):87-98
pubmed: 16459310
Leuk Lymphoma. 2019 Jul;60(7):1709-1720
pubmed: 30516071
Cell. 2016 Aug 11;166(4):1055-1056
pubmed: 27518567
Mol Cell. 2017 Apr 6;66(1):9-21.e7
pubmed: 28344080
Leuk Res. 2019 Oct;85:106198
pubmed: 31401408
Nat Genet. 2015 Mar;47(3):199-208
pubmed: 25599403
Genome Biol. 2005;6(8):R71
pubmed: 16086853
EMBO J. 2003 May 1;22(9):2274-83
pubmed: 12727893
Genomics. 2017 Oct;109(5-6):401-407
pubmed: 28655641
PLoS One. 2014 Mar 07;9(6):e90859
pubmed: 24609083
Blood. 2019 Oct 31;134(18):1533-1546
pubmed: 31387917
Cell Stem Cell. 2015 Apr 2;16(4):426-38
pubmed: 25772072
Blood. 2015 Feb 19;125(8):1302-13
pubmed: 25515961
Cell. 2005 Jan 14;120(1):21-4
pubmed: 15652478
Oncotarget. 2016 Jun 14;7(24):36366-36381
pubmed: 27119352
Front Genet. 2015 Jan 26;6:2
pubmed: 25674102
Genes Dev. 2009 Jul 1;23(13):1494-504
pubmed: 19571179
Leukemia. 1995 Aug;9(8):1305-12
pubmed: 7643617
Leukemia. 2006 Oct;20(10):1809-18
pubmed: 16932348
Mol Cell. 2004 Dec 22;16(6):861-5
pubmed: 15610730
J Biomol Struct Dyn. 2008 Aug;26(1):115-30
pubmed: 18533732
Mol Pharmacol. 2013 Aug;84(2):236-43
pubmed: 23696245
Clin Cancer Res. 2016 Jul 15;22(14):3537-49
pubmed: 26858310
Med Sci Monit. 2019 Jul 06;25:4999-5004
pubmed: 31278736
Oncotarget. 2015 Oct 13;6(31):31613-27
pubmed: 26436590
Nucleic Acids Res. 2012 Apr;40(7):3131-42
pubmed: 22140119
Haematologica. 2017 Dec;102(12):2039-2047
pubmed: 28971903
Nat Struct Mol Biol. 2006 Sep;13(9):754-5
pubmed: 16955093
Oncotarget. 2016 Feb 23;7(8):8601-12
pubmed: 26788991
Exp Hematol. 2019 Feb;70:42-54.e3
pubmed: 30395908
Hum Mol Genet. 2014 Jun 15;23(12):3278-88
pubmed: 24488769
Nat Biotechnol. 2014 May;32(5):453-61
pubmed: 24811520
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50
pubmed: 18308931
Leukemia. 2018 Oct;32(10):2152-2166
pubmed: 29467491
Blood. 2009 Apr 16;113(16):3801-8
pubmed: 18941118
Carcinogenesis. 2012 Jul;33(7):1294-301
pubmed: 22610076
J Cell Biochem. 2001;82(2):299-309
pubmed: 11527155
Biomed Pharmacother. 2019 Jan;109:1640-1649
pubmed: 30551418
Arthritis Rheum. 2008 Apr;58(4):1001-9
pubmed: 18383392
Genetics. 2013 Mar;193(3):651-69
pubmed: 23463798
Cancer Cell. 2016 Apr 11;29(4):452-463
pubmed: 27070700
Front Immunol. 2018 Jul 16;9:1649
pubmed: 30061899
Br J Haematol. 2016 Apr;173(2):318-20
pubmed: 26204929
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Cancer Sci. 2014 Apr;105(4):463-72
pubmed: 24720529
Nat Commun. 2019 Oct 25;10(1):4869
pubmed: 31653912
J Immunol. 2016 Mar 15;196(6):2799-2808
pubmed: 26880762
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):653-657
pubmed: 29950199
Radiat Prot Dosimetry. 2008;132(2):119-29
pubmed: 18922824
Cancer Manag Res. 2018 Oct 29;10:4999-5007
pubmed: 30464600
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3342-3347
pubmed: 29917184

Auteurs

Ajaz A Bhat (AA)

Translational Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.

Salma N Younes (SN)

Department of Biomedical Science, College of Health Sciences, Qatar University, Doha, Qatar.
Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.

Syed Shadab Raza (SS)

Laboratory for Stem Cell & Restorative Neurology, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India.

Lubna Zarif (L)

Department of Biomedical Science, College of Health Sciences, Qatar University, Doha, Qatar.
Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.

Sabah Nisar (S)

Translational Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.

Ikhlak Ahmed (I)

Translational Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.

Rashid Mir (R)

Department of Medical Lab Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.

Sachin Kumar (S)

Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Surender K Sharawat (SK)

Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Sheema Hashem (S)

Translational Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.

Imadeldin Elfaki (I)

Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.

Michal Kulinski (M)

Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.

Shilpa Kuttikrishnan (S)

Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.

Kirti S Prabhu (KS)

Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.

Abdul Q Khan (AQ)

Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.

Santosh K Yadav (SK)

Translational Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.

Wael El-Rifai (W)

Department of Surgery, University of Miami, Miami, Florida, USA.

Mohammad A Zargar (MA)

Department of Biotechnology, Central University of Kashmir, Ganderbal, Jammu and Kashmir, India.

Hatem Zayed (H)

Department of Biomedical Science, College of Health Sciences, Qatar University, Doha, Qatar.

Mohammad Haris (M)

Translational Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar. mharis@sidra.org.
Laboratory Animal Research Center, Qatar University, Doha, Qatar. mharis@sidra.org.

Shahab Uddin (S)

Translational Research Institute, Academic Health System, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar. Skhan34@hamad.qa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH